CROSSROADS STRATEGIES, LLC

Lobbying for MADRIGAL PHARMACEUTICALS, INC. · biopharmaceutical company

Filing 1st Quarter - Report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 20, 2026

Income

$50,000.00

What the client paid this registrant for the period.

Client based in

Pennsylvania

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 2

Health Issues

Issues related to drug pricing; Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Executive Order.

Medicare/Medicaid

Issues related to CMMI Drug Pricing Demonstration Programs.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.